Analysis of such differences between GCB and ABC subtypes could potentially give insight to explain why attempts to treat DLBCL patients, specifically based on GCB and ABC subtypes, with novel compounds have in large failed. The gene discussed is ABCB6; the disease is diffuse large B-cell lymphoma.